I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 8 studies | 39% ± 26% | |
| oligodendrocyte | 6 studies | 26% ± 8% | |
| endothelial cell | 5 studies | 24% ± 5% | |
| GABAergic neuron | 5 studies | 47% ± 21% | |
| astrocyte | 5 studies | 31% ± 12% | |
| natural killer cell | 5 studies | 17% ± 1% | |
| interneuron | 5 studies | 42% ± 24% | |
| oligodendrocyte precursor cell | 4 studies | 26% ± 8% | |
| B cell | 3 studies | 19% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 16% ± 1% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 1% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| GABAergic interneuron | 3 studies | 16% ± 1% | |
| epithelial cell | 3 studies | 32% ± 8% | |
| dendritic cell | 3 studies | 26% ± 7% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 16% ± 1% | |
| gamma-delta T cell | 3 studies | 24% ± 11% | |
| neuron | 3 studies | 23% ± 8% |
